Healthcare

Curasight Announces Preliminary Readout from its Phase 1 Clinical Trial with uTREAT® in Aggressive Brain Cancer (Glioblastoma)

COPENHAGEN, Denmark, June 8, 2026, 03:56 GMT-04

Curasight

Read full article →

Dayspring Pharma Announces Positive Topline Results from Phase II Clinical Trial of CG2001 for the Treatment of Androgenetic Alopecia (AGA)

SEOUL, South Korea, June 8, 2026, 21:28 GMT-04

DayspringPharma

Read full article →

Apheresis Market worth $4.41billion by 2031 | MarketsandMarkets™

DELRAY BEACH, Fla., June 5, 2026, 10:30 GMT-04

MarketsAndMarkets

Read full article →

Optellum Celebrates Accelerating Impact in Lung Cancer Care; Now at Over 250 Sites and Growing

OXFORD, United Kingdom and HOUSTON, June 5, 2026, 03:00 GMT-04

Optellum-Growing

Read full article →

USA Labels Market to Reach USD 23.2 Billion by 2035 as Smart Labeling, Digital Printing, and Compliance-Driven Packaging Transform Product Communication

NEWARK, Del., June 4, 2026, 12:00 GMT-04

FMI-USALabels

Read full article →

Roche rapidly develops a PCR test for Ebola within six days as rare Bundibugyo virus drives urgent need for detection

BERLIN, June 4, 2026, 11:59 GMT-04

Roche-Develops-PCR

Read full article →

Mesenchymal Stem Cells Market Forecast 2031: 12%+ CAGR, Growing Clinical Research & Regenerative Medicine Applications to Drive Market Expansion, Says Mordor Intelligence

HYDERABAD, India, June 4, 2026, 11:21 GMT-04

MORDOR-stem-cells-mkt

Read full article →

Generalized Anxiety Disorder Market Forecast Shows Strong CAGR During the Forecast Period (2026-2036) Driven by Innovative Therapies | DelveInsight

LAS VEGAS, June 4, 2026, 10:01 GMT-04

DELVEINSIGHT-GAD

Read full article →

Innovative Drug Update | Kexing Biopharm Enrolls First Subject in China-based Phase I Clinical Trial of Ophthalmic Innovative Drug GB10

SHENZHEN, China, June 4, 2026, 07:09 GMT-04

Kexing-Biopharm

Read full article →

Point of Care Testing Market Poised for US$ 64.8 Bn Valuation by 2031, Growing at 7.5% CAGR, New Report by Wissen Research

SHERIDAN, Wyo., June 3, 2026, 11:43 GMT-04

WISSEN-POCT-Research

Read full article →

T-cell Malignancies Market to Accelerate Substantially at a CAGR of 5.2% During the Forecast Period (2026-2036) | DelveInsight

LAS VEGAS, June 3, 2026, 10:01 GMT-04

DELVEINSIGHT

Read full article →

KrystoLens from Brain Navi Receives TFDA Certification, Set to Enter Taiwan Market

ZHUBEI, June 3, 2026, 09:30 GMT-04

Brain-Navi

Read full article →

HBSUK and Hexaware partner to enhance clinician onboarding efficiency

MUMBAI, India, ISELIN, N.J. and LONDON, June 3, 2026, 06:26 GMT-04

HEXAWARE-HBSUK-collab

Read full article →

Demand for Compounding Pharmacies in USA to Reach USD 12.79 Billion by 2036 Amid Growing Need for Personalized Therapies and Specialized Medication Solutions

NEWARK, Del., June 2, 2026, 14:44 GMT-04

FMI-Pharmacies

Read full article →

Injectable Drug Delivery Market Size to Grow from US$655.1 Billion in 2026 to US$1182.2 Billion by 2033 | Persistence Market Research

LONDON, June 2, 2026, 11:17 GMT-04

Persistence-Drug-Deli

Read full article →

Cardiac Marker Testing Market worth $9.06 billion by 2031 | MarketsandMarkets™

DELRAY BEACH, Fla., June 2, 2026, 10:30 GMT-04

MARKETSANDMARKETS

Read full article →

Cervical Dystonia Market to Witness Robust Growth During the Forecast Period (2026-2036) Driven by the Expanding Therapeutic Options | DelveInsight

LAS VEGAS, June 2, 2026, 10:01 GMT-04

DELVEINSIGHT

Read full article →

Advanced NanoTherapies Secures Over $31M Series B to Deliver First-of-its-Kind Dual-Drug (Paclitaxel and Sirolimus) Nanoparticle-Coated Balloon Platform for Vascular Treatment

SANTA CLARA, Calif., June 2, 2026, 09:42 GMT-04

AdvancedNanoTherapies

Read full article →

YuLife turns June into a movement for good, bringing Bupa's Healthy Cities programme to its full UK member base

LONDON, June 2, 2026, 05:00 GMT-04

YuLife-UK-Member-Base

Read full article →

AbbVie Announces European Commission Approval of AQUIPTA® (atogepant) for the Acute Treatment of Migraine in Adults

NORTH CHICAGO, Ill., June 2, 2026, 04:00 GMT-04

AbbVie-AQUIPTA-EC-App

Read full article →